Cite

HARVARD Citation

    Ruffolo, L. et al. (n.d.). Blockade Of The Semaphorin 4d-Plexin B1/B2 Axis Sensitizes Pancreatic Cancer To Immune-Checkpoint Therapy When Combined With Folfirinox. HPB. pp. S13-S14. [Online]. 
  
Back to record